Protocol for Holding Clopidogrel Prior to Surgery
For elective surgery, discontinue clopidogrel at least 5 days before the procedure, and resume as soon as hemostasis is achieved postoperatively. 1, 2
Standard Elective Surgery Protocol
Timing of Discontinuation
Discontinue clopidogrel 5 days before elective surgery to allow adequate platelet function recovery, as clopidogrel irreversibly inhibits platelet aggregation for the lifetime of the platelet (7-10 days). 1, 2
For CABG specifically, the American Heart Association guidelines recommend discontinuation for 5-7 days before elective surgery, with 7 days being preferable for optimal platelet recovery. 3, 1
Prasugrel requires 7 days of discontinuation before surgery due to its more potent and prolonged antiplatelet effects. 4, 1
Ticagrelor requires only 5 days of discontinuation before surgery. 4, 1
Resumption After Surgery
- Resume clopidogrel as soon as hemostasis is achieved postoperatively, typically within 24-48 hours, as discontinuation increases cardiovascular event risk. 2
Urgent/Emergency Surgery Protocol
For urgent surgery where waiting 5 days is not feasible, discontinue clopidogrel for at least 24 hours to reduce major bleeding risk, though this carries increased bleeding risk compared to the full 5-day washout. 1
This 24-hour minimum applies specifically to urgent CABG situations where delaying surgery poses greater risk than the bleeding risk from recent clopidogrel exposure. 1
Experienced surgeons may proceed with "early" CABG (within 5 days of clopidogrel) at acceptable incremental bleeding risk in urgent situations, though blood transfusion requirements increase. 3
Risk Stratification for Decision-Making
High Thrombotic Risk Patients (Defer Surgery if Possible)
Patients at high risk for thrombotic events should have elective procedures deferred until clopidogrel can be safely discontinued for the full 5-7 days. 5
High-risk features include:
- Drug-eluting stents placed within 12 months 4
- Bare-metal stents placed within 1 month 6
- Recent acute coronary syndrome (within weeks to months) 4
- Recent stroke or TIA 4
For these patients, cardiology consultation is mandatory before any clopidogrel interruption to assess thrombotic versus bleeding risk. 7
Aspirin Management
Continue aspirin throughout the perioperative period unless the bleeding risk is prohibitive, as aspirin alone poses minimal bleeding risk and provides critical cardiovascular protection. 1, 7
- For patients on dual antiplatelet therapy (clopidogrel + aspirin), stopping clopidogrel while continuing aspirin reduces bleeding risk while maintaining some cardiovascular protection. 5
Procedure-Specific Considerations
High Bleeding Risk Procedures
For procedures with high bleeding risk in closed spaces (neurosurgery, retinal surgery, spinal procedures):
- Require the full 5-7 day discontinuation period without exception. 6, 8
- These procedures have catastrophic consequences from even minor bleeding. 8
Moderate Bleeding Risk Procedures
For endoscopic procedures with high bleeding risk (polypectomy, sphincterotomy, endoscopic submucosal dissection):
- Discontinue clopidogrel for 7 days before the procedure. 5
- Continue aspirin if cardiovascular risk is high. 5
Lower Bleeding Risk Procedures
Recent research suggests that for peripheral arterial surgery and some major vascular procedures, continuing clopidogrel may be safe and does not significantly increase bleeding complications. 9, 10
However, guideline recommendations still favor the 5-day discontinuation protocol for consistency and to minimize medicolegal risk. 1, 2
Common Pitfalls to Avoid
Do not stop clopidogrel for less than 5 days in elective surgery unless the thrombotic risk clearly outweighs bleeding risk, as 3-4 days provides inadequate platelet recovery. 11
Do not delay resumption of clopidogrel postoperatively beyond achieving hemostasis, as each day without antiplatelet therapy increases thrombotic event risk. 2
Do not discontinue both aspirin and clopidogrel simultaneously in high-risk cardiac patients unless absolutely necessary for the procedure. 5
Do not proceed with elective surgery in patients with recent drug-eluting stents (within 12 months) without cardiology consultation, as stent thrombosis carries 20-45% mortality. 4
Evidence Quality Note
While the 5-day discontinuation protocol is based on Class I, Level C evidence (expert consensus rather than randomized trials), it remains the standard of care endorsed by the American College of Cardiology and American Heart Association. 1, 2 Some recent observational studies suggest shorter discontinuation periods (3 days) may be adequate, but these have not been validated in prospective trials and should not change current practice. 12, 11